Table I.
Summary of alopecia areata-like presentations following mogamulizumab therapy
| Source | Age | Sex | Alopecia presentation | Time to alopecia onset | Findings | CTCL response at time of alopecia presentation |
|---|---|---|---|---|---|---|
| Raval et al2 | 42 | F | Alopecia Universalis | 16 mo | - bx: reduced follicle count, follicles in telogen | Complete |
| Amatore et al∗,3 | 58 | F | Alopecia Totalis | 16 mo | - decreased peripheral Tregs | Complete |
| 71 | F | Alopecia Totalis | 6 mo | - decreased peripheral Tregs | Complete | |
| 35 | F | Alopecia Totalis | 14 mo | NR | Partial | |
| 81 | M | Ophiasis | 11 mo | NR | Partial | |
| Bonnet et al4 | 61 | F | Alopecia Areata | 3 mo | - decreased peripheral Tregs | Complete |
| Present case | 71 | M | Alopecia Universalis | 6 mo | - bx: intrafollicular CD8+ lymphocytes | Complete |
bx, Biopsy; NR, none reported; Treg, regulatory T-cells.
∗
Two biopsies showed peribulbar CD8+ T-cell infiltration, however patients that had biopsies were not specified.